Pharmaceutical Care for Patients with Chronic Obstructive Pulmonary Disease_West China Medical Journal

Authors：

REN Qiang , ZHENG Yongchi

Department of Pharmacy, People′s Hospital of Dujiangyan, Chengdu, Sichuan 611830, P. R. China;

Corresponding author：

Keywords：

慢性阻塞性肺疾病; 药学监护; 临床药师

Video：

Export PDF Favorites Scan Get Citation

Abstract Full text Figures/Tables Video References Cited by

【摘要】　目的　探讨慢性阻塞性肺疾病（chronic obstructive pulmonary disease，COPD）治疗方案及药学监护的内容。　方法　以2007年12月收治的1例COPD患者为例，结合COPD治疗指南，为COPD急性加重期患者制定个体化的药学监护计划并实施全程的药学监护。　结果　患者COPD急性加重期的药物治疗方案有效合理。通过全程的药学监护，及时发现和解决了患者药物治疗的问题，为临床合理用药提供了意见。　结论　对COPD患者实施药学监护具有可行性和实用性。
【Abstract】　Objective　 To investigate the treatment and pharmaceutical care for chronic obstructive pulmonary disease (COPD) patients.　Methods　 In December 2007, a patient with COPD was diagnosed, and based on the clinical data, COPD treatment guidelines were adopted to analyze treatment plans. For patients with acute exacerbation of COPD, individualized pharmaceutical care plan was proposed, and pharmaceutical care was performed during the whole course of disease.　Results　 The drug treatment for the one patient with acute exacerbation of COPD was effective and reasonable. Treatment problems were observed and solved through pharmaceutical care which had given reasonable suggestions for medication.　Conclusion　 The implementation of pharmaceutical care for COPD patients is feasible and practical.

Citation： REN Qiang,ZHENG Yongchi. Pharmaceutical Care for Patients with Chronic Obstructive Pulmonary Disease. West China Medical Journal, 2011, 26(12): 1853-1855. doi: Copy

1.	中华医学会呼吸病学分会慢性阻塞性肺疾病学组. COPD诊治指南2007年修订版[J]. 继续教育, 2007, 21(2): 31-42.
2.	Sethi S, Murphy TF. Infection in the pathogenesis and course ofchronic obstructive pulmonary disease[J]. N Engl J Med, 2008, 359(22): 2355-2365.
3.	周庆涛, 贺蓓. 慢性阻塞性肺疾病急性加重期的抗菌药物应用——COPD指南解读[J]. 中国药物应用与监测, 2011, 8(2): 65-68.
4.	Seemungal TAR, Wilkinson TMA, Hurst JR, et al. Long-termerythromycin therapy is associated with decreased chronic obstructive pulmonary disease exacerbations[J]. Am J Respir Crit Care Med, 2008, 178(11): 1139-1147.
5.	Vestbo J, Sorensen T, Lange P, et al. Long-term effect of inhaled budesonide in mile and moderate chronic obstructive pulmonary disease:a randomized controlled trial[J]. Lancet, 1999, 353(9167): 1819-1823.
6.	Luncel Health Study Research Group. Effect of inhaled triamcinolone on the decline in pulmonary function in chronic obstructive pulmonary disease[J]. N Engl J Med, 1999, 343(26): 1902-1909.
7.	叶晓芬, 蔡映云, 吕迁洲. 临床药师对住院病人如何开展药学监护[J]. 中国执业药师, 2009, 2(6): 8-10.

1. 　中华医学会呼吸病学分会慢性阻塞性肺疾病学组. COPD诊治指南2007年修订版[J]. 继续教育, 2007, 21(2): 31-42.
2. 　Sethi S, Murphy TF. Infection in the pathogenesis and course ofchronic obstructive pulmonary disease[J]. N Engl J Med, 2008, 359(22): 2355-2365.
3. 　周庆涛, 贺蓓. 慢性阻塞性肺疾病急性加重期的抗菌药物应用——COPD指南解读[J]. 中国药物应用与监测, 2011, 8(2): 65-68.
4. 　Seemungal TAR, Wilkinson TMA, Hurst JR, et al. Long-termerythromycin therapy is associated with decreased chronic obstructive pulmonary disease exacerbations[J]. Am J Respir Crit Care Med, 2008, 178(11): 1139-1147.
5. 　Vestbo J, Sorensen T, Lange P, et al. Long-term effect of inhaled budesonide in mile and moderate chronic obstructive pulmonary disease:a randomized controlled trial[J]. Lancet, 1999, 353(9167): 1819-1823.
6. 　Luncel Health Study Research Group. Effect of inhaled triamcinolone on the decline in pulmonary function in chronic obstructive pulmonary disease[J]. N Engl J Med, 1999, 343(26): 1902-1909.
7. 　叶晓芬, 蔡映云, 吕迁洲. 临床药师对住院病人如何开展药学监护[J]. 中国执业药师, 2009, 2(6): 8-10.

West China Medical Journal

Pharmaceutical Care for Patients with Chronic Obstructive Pulmonary Disease

Abstract Full text Figures/Tables Video References Cited by

Format

Content